Does LANREOTIDE Cause Injection site atrophy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site atrophy have been filed in association with LANREOTIDE (Lanreotide Acetate). This represents 0.1% of all adverse event reports for LANREOTIDE.
5
Reports of Injection site atrophy with LANREOTIDE
0.1%
of all LANREOTIDE reports
3
Deaths
4
Hospitalizations
How Dangerous Is Injection site atrophy From LANREOTIDE?
Of the 5 reports, 3 (60.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Injection site atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANREOTIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LANREOTIDE Cause?
Diarrhoea (1,646)
Off label use (1,536)
Death (1,177)
Fatigue (1,022)
Nausea (775)
Abdominal pain (662)
Injection site pain (618)
Malaise (520)
Headache (515)
Asthenia (483)
What Other Drugs Cause Injection site atrophy?
GLATIRAMER (282)
ASFOTASE ALFA (144)
TRIAMCINOLONE ACETONIDE (121)
INTERFERON BETA-1A (103)
INTERFERON BETA-1B (44)
TRIAMCINOLONE (34)
INSULIN GLARGINE-YFGN (27)
MEDROXYPROGESTERONE (22)
INSULIN GLARGINE (17)
SOMATROPIN (17)
Which LANREOTIDE Alternatives Have Lower Injection site atrophy Risk?
LANREOTIDE vs LANSOPRAZOLE
LANREOTIDE vs LANTHANUM
LANREOTIDE vs LANTUS
LANREOTIDE vs LANTUS SOLOSTAR
LANREOTIDE vs LAPATINIB